# Prevalence of COVID-19 in High Altitude : Insights From the Highest City of the World

> **NCT04604249** · — · UNKNOWN · sponsor: **Centre d'Expertise sur l'Altitude EXALT** · enrollment: 200 (estimated)

## Conditions studied

- Covid19
- High Altitude

## Interventions

- **DIAGNOSTIC_TEST:** SARS-CoV-2 rapid diagnostic test (COVID-PRESTO® IgM/IgG, AAZ, Boulogne-Billancourt, France)

## Key facts

- **NCT ID:** NCT04604249
- **Lead sponsor:** Centre d'Expertise sur l'Altitude EXALT
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-26
- **Primary completion:** 2021-11-30
- **Final completion:** 2021-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2021-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04604249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04604249, "Prevalence of COVID-19 in High Altitude : Insights From the Highest City of the World". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04604249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*